Cargando…

Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast

BACKGROUND: The immune microenvironment in ductal carcinoma in situ (DCIS) and its significance are not well established. This study was conducted to evaluate the immune microenvironment of DCIS including the composition of tumor-infiltrating lymphocyte (TIL) subsets and PD-L1+ immune cells and to c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Milim, Chung, Yul Ri, Kim, Hyun Jeong, Woo, Ji Won, Ahn, Soomin, Park, So Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098119/ https://www.ncbi.nlm.nih.gov/pubmed/32216826 http://dx.doi.org/10.1186/s13058-020-01267-w

Ejemplares similares

Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes
por: Kim, Milim, et al.
Publicado: (2018)

Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast
por: Kim, Milim, et al.
Publicado: (2021)

Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers
por: Woo, Ji Won, et al.
Publicado: (2020)

Clinical implications of changes in the diversity of c-MYC copy number variation after neoadjuvant chemotherapy in breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2018)

Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer
por: Ahn, Soomin, et al.
Publicado: (2020)

Mammary Carcinoma Arising in Microglandular Adenosis: A Report of Five Cases
por: Kim, Mimi, et al.
Publicado: (2017)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma: morphology, molecular portraits, and the tumor microenvironment
por: Chen, Weiling, et al.
Publicado: (2022)

Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer
por: Ahn, Soomin, et al.
Publicado: (2018)

Comparison of the Characteristics of Medullary Breast Carcinoma and Invasive Ductal Carcinoma
por: Park, Inhye, et al.
Publicado: (2013)

Clinicopathologic Features and Outcomes of Metaplastic Breast Carcinoma: Comparison with Invasive Ductal Carcinoma of the Breast
por: Park, Hyung Seok, et al.
Publicado: (2010)

Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience
por: Kim, Milim, et al.
Publicado: (2018)

Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ: A retrospective cohort study
por: Guan, Xin, et al.
Publicado: (2020)

An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast
por: Kim, Sanghwa, et al.
Publicado: (2019)

Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ
por: Sameni, Mansoureh, et al.
Publicado: (2017)

Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma
por: Lee, Jeeyeon, et al.
Publicado: (2020)

Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer
por: Han, Song-Hee, et al.
Publicado: (2022)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
por: Tamimi, Rulla M, et al.
Publicado: (2008)

The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
por: Toss, Michael S., et al.
Publicado: (2020)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020)

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast
por: Robanus-Maandag, E, et al.
Publicado: (2000)

The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
por: Niwińska, Anna, et al.
Publicado: (2021)

Tubular Carcinoma of the Breast: Clinicopathologic Features and Survival Outcome Compared with Ductal Carcinoma In Situ
por: Min, Yejin, et al.
Publicado: (2013)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ
por: Zhou, Wenjing, et al.
Publicado: (2013)

The Impact of Androgen Receptor and Histone Deacetylase 1 Expression on the Prognosis of Ductal Carcinoma In Situ
por: Lee, Choong Man, et al.
Publicado: (2020)

Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in Ductal Carcinoma in Situ and Invasive Ductal Carcinoma of the Breast
por: Kim, Hee Jung, et al.
Publicado: (2006)

Predictors of Recurrent Ductal Carcinoma In Situ after Breast-Conserving Surgery
por: Kim, Jung Yeon, et al.
Publicado: (2016)

Non-Calcified Ductal Carcinoma in Situ: Ultrasound and Mammographic Findings Correlated with Histological Findings
por: Cho, Kyu Ran, et al.
Publicado: (2008)

Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast
por: Son, Seung Hyun, et al.
Publicado: (2014)

EGFR Gene Amplification and Protein Expression in Invasive Ductal Carcinoma of the Breast
por: Hwangbo, Won, et al.
Publicado: (2013)

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004)

Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast
por: Park, Jun Su, et al.
Publicado: (2015)

Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women
por: Ko, Hyeonyoung, et al.
Publicado: (2017)

Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
por: Zubeldia-Plazaola, Arantzazu, et al.
Publicado: (2018)

Identification of aberrant gene expression during breast ductal carcinoma in situ progression to invasive ductal carcinoma
por: Song, Guiqin, et al.
Publicado: (2019)

Triexponential Diffusion Analysis of Diffusion-weighted Imaging for Breast Ductal Carcinoma in Situ and Invasive Ductal Carcinoma
por: Ohno, Masako, et al.
Publicado: (2021)

Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
por: Liu, Yang, et al.
Publicado: (2023)

Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy
por: Lee, Kwan Ho, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_asmcnaom3r198cg33ar85fd105